Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 215-222

  Liuba, Petru ^a   Pesonen, Erkki ^a   Paakkari, Ilari ^b   Batra, Satish ^a   Forslid, Anders ^a   Kovanen, Petri ^c   Pentikäinen, Markku ^c   Persson, Kenneth ^a   Sandström, Staffan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Wihuri Institute   (Finland)

Author keywords

Acute infection; Chlamydia pneumoniae; Coronary; Endothelium

Indexed keywords

ANTIOXIDANT; ARGININE; BRADYKININ; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; ENDOTHELIUM LESION; FIBRINOGEN BLOOD LEVEL; INOCULATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION; VASOMOTOR REFLEX;

EID: 0038801326     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00019-4     Document Type: Article

References (30)

1. Meier C., Jick S., Derby L., et al. Acute respiratory tract infections and risk of first-time acute myocardial infarction. Lancet. 351:1998;1467-1471.
2. Pesonen E., Siitonen O. Acute myocardial infarction precipitated by infection: clinical clues. Am. Heart J. 101:1981;512-513.
3. Spodick D., Flessas A., Johnson M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am. J. Cardiol. 53:1984;481-482.
4. Kuo C., Jackson L., Campbell L., Grayston T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:1995;451-461.
5. Mendall M., Carrington D., Strachan D., et al. Chlamydia pneumoniae - risk factors for seropositivity and association with coronary heart disease. J. Infect. 30:1995;21-28.
6. Saikku P. Chlamydia pneumoniae as a risk factor in acute myocardial infarction. Eur. Heart J. 14:1993;K62-K65.
7. Aceti A., Mazzacurati G., Amendola M.A., et al. H pylori and C. pneumoniae may account for most acute coronary syndrome. Br. Med. J. 313:1996;428-429.
8. Mazzoli S., Tofani N., Fantini A., et al. Chlamydia pneumoniae antibody response and in patients with acute myocardial infarction and their follow up. Am. Heart J. 135:1998;15-20.
9. Blasi F., Cosentini R., Raccanelli R. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 112:1997;309-312.
10. Wimmer M., Sandmann-Strupp R., Saikku P., Haberl R. Association of chlamydial infection with cerebrovascular disease. Stroke. 27:1996;2207-2210.
11. Vallance P., Colloer J., Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 349:1997;1391-1392.
12. Libby P., Egan D., Skarlatos S. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 96:1997;4095-4103.
13. Deedwania P. Endothelium - a new target for cardiovascular therapeutics. J. Am. Coll. Cardiol. 35:2000;67-70.
14. Liuba P., Karnani P., Pesonen E., et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation. 102:2000;1039-1044.
15. Denardo S., Talbot L., Hargrave V., et al. Accuracy of Doppler catheter measurements: effect of inhomogeneous beam power distribution on mean and peak velocity. J. Am. Coll. Cardiol. 29:1997;283-292.
16. Al-Hijji J., Larsson B., Batra S. Nitric oxide synthase in the rabbit uterus and vagina: hormonal regulation and functional significance. Biol. Reprod. 62:2000;1387-1392.
17. Bhagat K., Collier J., Vallance P. Endothelial stunning following a brief exposure to endotoxin: a mechanism to link infection with infarction? Cardiovasc. Res. 32:1996;822-829.
18. Wang P., Ba E., Chaudry H. Administration of TNF-alpha in vivo depresses endothelium-dependent relaxation. Am. J. Physiol. 266:1995;H2535-H2541.
19. Hingorani A., Cross J., Kharbanda R., et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 102:2000;994-999.
20. Leinonen M., Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet. 2:2002;11-17.
21. Danser A., Tom B., de Vries R., et al. L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition. Br. J. Pharmacol. 131:2000;195-202.
22. Kothe H., Dalhoff K., Rupp J., et al. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation. 101:2000;1760-1763.
23. Faracci F., Gunnett C., Heistad G., et al. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. 279:(4):2000;H1555-H1562.
24. Tanner F., Noll G., Boulanger C., et al. Oxidized LDL inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020.
25. Crow J., Beckman J. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol. Chemother. 34:1995;17-43.
26. Hecker M., Sessa W., Harris H., et al. The metabolism of L-arginine and its significance of for the biosynthesis of endothelium-derived relaxing factor: culture endothelial cells recycle L-citruline to L-arginine. Proc. Natl. Acad. Sci. USA. 87:1990;8612-8616.
27. Behrendt D., Ganz P. Endothelial function: from vascular biology to clinical applications. Am. J. Cardiol. 90:2002;40-48.
28. 2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ. Res. 75:1994;659-668.
29. Cooke J., Dzau V. Derangements of the nitric oxide synthase pathway, L-arginine and cardiovascular diseases. Circulation. 96:1997;379-382.
30. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387.